COLL – collegium pharmaceutical, inc. (US:NASDAQ)

News

Collegium Pharmaceutical (COLL) was downgraded by Weiss Ratings from "buy (b-)" to "hold (c+)".
Collegium to Present New Real-World Data at PainConnect 2026
Paris Hilton Shares Her Experience with JORNAY PM and Launches New 'Embrace Your Sparkle' Campaign with Collegium to Empower the ADHD Community [Yahoo! Finance]
Paris Hilton Shares Her Experience with JORNAY PM and Launches New 'Embrace Your Sparkle' Campaign with Collegium to Empower the ADHD Community
Collegium to Participate in Upcoming Investor Conferences
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com